Active, not recruitingPhase 2NCT02866136

Conservative Treatments of Retinoblastoma

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut Curie
Principal Investigator
Isabelle Aerts, MD
Institut Curie - Paris - France
Intervention
VP16, carboplatin(drug)
Enrollment
133 enrolled
Eligibility
6 years · All sexes
Timeline
2012 – 2035

Study locations (1)

Collaborators

Fondation Rothschild Paris

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02866136 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials